HeartSine® Technologies is pleased to announce the arrival of the samaritan® PAD 360P, a fully automatic AED (Automatic External Defibrillator) based on the company’s popular samaritan PAD 350P.
The HeartSine samaritan PAD 360P (SAM 360P) analyses the heart rhythm and delivers an electrical shock to a victim of Sudden Cardiac Arrest in order to restore the heart to normal rhythm. …
July 21, 2014
HeartSine Technologies, a world leader in personal and public access defibrillators, has appointed Hugh Hennessy as Commercial Director. Based in the company’s Northern Ireland facility, Hennessy will strengthen the sales and support organization for the European, African and Asian markets.
Hennessy is a veteran sales executive with a vast experience in consumer electronics and telecommunications sales and marketing, working with …
July 10, 2014
HeartSine® Technologies, a world leader in personal and public access defibrillators, is an official sponsor of the 2014 Federation of International Lacrosse World Championship, presented by Trusted Choice, providing its popular samaritan® PAD automatic external defibrillators (AED) for the medical tents at the event.
June 20, 2014
HeartSine Technologies, the Belfast-based innovator of defibrillator technology, has won a national business award from the British Private Equity & Venture Capital Association (BVCA).
Dymphna Donaghy, Chief Technical Officer of HeartSine Technologies, picked up the prize at the BVCA Management Team Awards, held last night in London.
Produced in partnership with Grant Thornton, the awards are an annual celebration of …
May 12, 2014
HeartSine, a world leader in personal and public access defibrillators, has won two prestigious BVCA (British Private Equity & Venture Capital Association) Management Team Awards for the Northern Ireland region: Private Equity-backed Management Team of the Year (Mid Market) Award and International Impact Management Team of the Year Award.
Open to management teams of mid-market private equity-backed companies, the Private …
May 9, 2014
The Department for Education (DfE) in the United Kingdom has announced plans that would allow schools to purchase lifesaving defibrillators at a lower cost; a deal which will hopefully be in place for the beginning of the Autumn term.
The plans were welcomed by HeartSine Chief Executive, Declan O’Mahoney, who said:
“There is a misconception that Sudden Cardiac Arrest …
May 5, 2014
HeartSine Technologies, a world leader in personal and public access defibrillators, has appointed Paul Phillips as Vice President of Quality and Regulatory Affairs. Based in the company’s Northern Ireland manufacturing facility, Phillips will lead HeartSine’s global quality, regulatory and compliance teams in Europe and the U.S.
Phillips is a seasoned medical technology industry executive with over 35 …
Utah State Parks Uses AAA Donation to Purchase HeartSine Samaritan Public Access Defibrillators to Help Ensure the Safety of VisitorsMay 1, 2014
Utah State Parks, which manages numerous parks and access to waterways, is using part of a $75,000 donation from AAA Utah to obtain HeartSine® samaritan® Public Access Defibrillators (PADs) to protect its visitors who are often in remote locations where access to emergency services is limited.
By obtaining the Automatic External Defibrillators (AED), Utah State Parks is seeking to increase …
April 30, 2014
Dr Peter O’Hare of HeartSine’s Clinical Engineering Research Group has been invited to present research on the company’s patented CPR Advisor platform at Resuscitation 2014, the Congress of the European Resuscitation Council (ERC).
During his presentation entitled “The Correlation between the Impedance Cardiogram and End-tidal Carbon Dioxide during Cardiopulmonary Resuscitation in Cardiac Arrest,” Dr O’Hare will discuss how CPR Advisor …
March 10, 2014
Due to her wealth of experience, Colette McIntyre, HeartSine’s Good Laboratory Practice/Good Clinical Practice Specialist, has been appointed to the medical devices committee of the Research Quality Association (RQA).
The RQA, an association for professionals working in research in pharmaceuticals, agrochemicals, chemicals and medical devices, drives quality and integrity in scientific research and development by developing and promoting quality …